LEX-210: A phase 3, randomized, double-blinded study of four-factor prothrombin complex concentrate in patients with acute major bleeding on direct oral anticoagulant therapy with factor Xa inhibitors

Category Primary study
ConferenceResearch and Practice in Thrombosis and Haemostasis
Year 2022
This article has no abstract
Epistemonikos ID: 332d8860a498916e6ee55f3f4db130dbf8816986
First added on: Apr 30, 2026